Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

BACKGROUND: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer. METHODS: In this phase 3, open-label study, we randomly assigned previously untreated patients in East Asia who had advanced p...

Full description

Saved in:
Bibliographic Details
Main Authors: Tony S. Mok, Yi Long Wu, Sumitra Thongprasert, Chih Hsin Yang, Da Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose, Yutaka Nishiwaki, Yuichiro Ohe, Jin Ji Yang, Busyamas Chewaskulyong, Haiyi Jiang, Emma L. Duffield, Claire L. Watkins, Alison A. Armour, Masahiro Fukuoka
Format: Journal
Published: 2018
Subjects:
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=69949162760&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/59797
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=69949162760&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/59797

Similar Items